According to Zacks, “Omnova Solutions Inc. develops, manufactures and markets emulsion polymers, specialty chemicals and decorative and building products for a variety of industrial, commercial and consumer markets. The Performance Chemicals unit’s broad range of emulsion polymers and specialty chemicals are used as coatings, binders, adhesives, and additives for paper, carpet, textile and various other industries. “
Several other equities research analysts have also recently commented on the company. Jefferies Group reissued a buy rating on shares of Omnova Solutions in a research note on Wednesday, July 6th. TheStreet raised Omnova Solutions from a sell rating to a hold rating in a research note on Friday, July 22nd.
Shares of Omnova Solutions (NYSE:OMN) opened at 8.19 on Friday. The company’s market cap is $368.67 million. Omnova Solutions has a 52 week low of $4.37 and a 52 week high of $10.42. The company has a 50 day moving average of $9.58 and a 200-day moving average of $7.72.
Omnova Solutions (NYSE:OMN) last announced its quarterly earnings results on Thursday, September 22nd. The company reported $0.14 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.17 by $0.03. The firm earned $195.60 million during the quarter. Omnova Solutions had a negative net margin of 1.57% and a positive return on equity of 18.11%. The business’s quarterly revenue was down 7.3% compared to the same quarter last year. During the same period last year, the firm posted $0.13 earnings per share. On average, equities research analysts expect that Omnova Solutions will post $0.55 earnings per share for the current fiscal year.
In other Omnova Solutions news, SVP Douglas E. Wenger sold 8,671 shares of the company’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $9.73, for a total transaction of $84,368.83. Following the completion of the sale, the senior vice president now owns 168,408 shares of the company’s stock, valued at $1,638,609.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 6.76% of the company’s stock.
Large investors have recently bought and sold shares of the stock. American Century Companies Inc. boosted its stake in Omnova Solutions by 86.2% in the second quarter. American Century Companies Inc. now owns 75,437 shares of the company’s stock valued at $547,000 after buying an additional 34,926 shares in the last quarter. Acadian Asset Management LLC boosted its stake in Omnova Solutions by 51.6% in the second quarter. Acadian Asset Management LLC now owns 18,472 shares of the company’s stock valued at $134,000 after buying an additional 6,290 shares in the last quarter. Nordea Investment Management AB acquired a new stake in Omnova Solutions during the second quarter valued at $1,077,000. Royal Bank of Canada boosted its stake in Omnova Solutions by 3.4% in the first quarter. Royal Bank of Canada now owns 4,144,559 shares of the company’s stock valued at $23,043,000 after buying an additional 137,590 shares in the last quarter. Finally, Barington Capital Group L.P. boosted its stake in Omnova Solutions by 4.6% in the first quarter. Barington Capital Group L.P. now owns 971,825 shares of the company’s stock valued at $5,403,000 after buying an additional 43,038 shares in the last quarter. 85.19% of the stock is owned by institutional investors.
Omnova Solutions Company Profile
OMNOVA Solutions Inc (OMNOVA) is a provider of emulsion polymers, specialty chemicals and engineered surfaces for commercial, industrial and residential end uses. The Company operates in two segments: Performance Chemicals and Engineered Surfaces. OMNOVA Performance Chemicals segment produces a range of emulsion polymers and specialty chemicals based primarily on styrene butadiene (SB), styrene butadiene acrylonitrile (SBA), styrene butadiene vinyl pyridine, nitrile butadiene (NBR), polyvinyl acetate, acrylic, styrene acrylic, vinyl acrylic, glyoxal, fluorochemical and bio-based chemistries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Omnova Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnova Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.